Alireza Hamidian Jahromi
Volume1-Issue1
Dates: Received: 2020-05-14 | Accepted: 2020-05-25 | Published: 2020-05-26
Pages: 001-002
Abstract
In a recent viewpoint publication in the Journal of American Medical Association (JAMA), Onder, et al. provided insight into the coronavirus disease 2019 (COVID-19) outbreak in Italy along with an explanation of the Italian National Institute of Health (Istituto Superiore di Sanita [ISS]) surveillance system [1]. Onder calculated the overall attributed COVID-19 fatality rate of 7.2% in the Italian population, based on the data up to March 17th, 2020 (1625 deaths/22 512 cases) [1]. Onder and colleagues proposed the demographic characteristics of the Italian population (higher older age distribution in the population compared to some other nations) and the associated comorbidities, lack of clearly defined COVID-19 related deaths and the differences in calculation methods in Italy and internationally along with country-specific differences in testing strategies as possible explanations for the higher Italian case-fatality rate compared with some other nations (i.e. China) [1].
FullText HTML
FullText PDF
DOI: 10.37871/jels1111
Certificate of Publication
Copyright
© 2020 Hamidian Jahromi A, Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Hamidian Jahromi A. Analysis of Reported Case Fatality Rate and Characteristics of COVID-19 Patients in Italy. J Biomed Res Environ Sci. 2020 May 26; 1(1): 001-002. DOI: 10.37871/jels1111
Subject area(s)
University/Institute
References
- Onder G, Rezza G, Brusaferro S. Case fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323: 1775-1776. PubMed: https://pubmed.ncbi.nlm.nih.gov/32203977/
- Baud D, Qi X, Nielsen Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020: S1473-3099: 30195-X. PubMed: https://pubmed.ncbi.nlm.nih.gov/32171390/
- Kim DD, Goel A. Estimating case fatality rates of COVID-19. Lancet Infect Dis. 2020; S1473-3099: 30234-30236. PubMed: https://pubmed.ncbi.nlm.nih.gov/32243815/
- Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020; PubMed: https://pubmed.ncbi.nlm.nih.gov/32172228/
- Orrechio Egresitz H. A shortage of medical supplies and hospital beds in Italy is forcing doctors to choose which coronavirus patients to save and they’re said to be choosing the young. Bus Insid. March 2020. https://bit.ly/2LWpWuH
